Virtual Medicinal Product (VMP) - Pasireotide 40mg powder and solvent for suspension for injection vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Pasireotide 40mg powder and solvent for suspension for injection vials | Start Date 01-07-2015 | End Date |
| Abbreviated Name | Abbreviated Name Pasireotide 40mg inj vials | Start Date 01-07-2015 | |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder and solvent for suspension for injection
- Ontology Form/Route
- suspensioninjection.intramuscular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- H01CB05
- BNF Codes
-
- BNF code 08030403
| Code | Start Date | End Date |
|---|---|---|
| 29904011000001107 | 01-07-2015 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Pasireotide pamoate | Based on Base Substance | Pasireotide | 40 mg |
Name
Pasireotide pamoate
Basis of strength description
Based on Base Substance
BOSS
Pasireotide
Strength and UOM (Nmr)
40.0
Strength and UOM (Dmr)
Parent Products
-
VTMPasireotide
-
VMP(Current) Pasireotide 40mg powder and solvent ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |